Thrombophilia
Clinical Aspects | Genetic Causes | Acquired Causes
Genetic Causes of Venous Thrombosis
Specific genetic defects should be suspected when a thrombotic event has any of the following characteristics12,14,15:
- Spontaneous with no predisposing condition, such as prolonged immobilization or surgery
- Patient suffers from more than one thrombotic event
- Patient has a positive family history of thrombosis
- Patient is less than 50 years old
- Thrombosis occurs at an unusual site (eg, mesenteric or cerebral brain)
Three general categories of test methodology are useful in the assessment of congenital thrombotic conditions:
- Genetic tests for specific mutations
- Clotting-based measurements for specific factor activity levels
- Immunoassays to measure the concentration of specific antigens
Genetic conditions associated with thrombophilia are listed below in order of their relative frequency of occurrence.12,14,16
Table 1.-Genetic Conditions Associated With Thrombosis.
|
Genetic Condition
|
Testing Method
|
Test Number
|
|
Methylenetetrahydrofolate
Reductase (MTHFR) Gene Mutation
|
Screen: Homocysteine level
Confirmation: MTHFR genetic testing
|
706994
511238
|
|
Factor V Leiden Mutation
|
Screen: Activated protein C resistance
Confirmation: Genetic testing
|
117762
511154
|
|
Prothrombin 20210
|
Genetic testing only
|
511162
|
|
Increased Factor VIII *
|
Factor VIII activity
|
086264
|
|
Protein S Deficiency
|
Screen: Protein S activity Profile: (activity, total/free antigen)
|
164525 117754
|
|
Protein C Deficiency
|
Screen: Protein C activity profile (activity and antigen)
|
117705 080465
|
|
Antithrombin Deficiency
|
Screen: Antithrombin activity profile (activity and antigen)
|
015040 015594
|
|
Dysfibrinogenemia
|
Fibrinogen activity
Fibrinogen antigen
|
001610 117052
|
*While factor VIII elevation is associated with a number of acquired conditions, some individuals appear to have congenitally elevated factor VIII levels that are associated with increased risk of thrombosis.12
Genetic testing is useful for the diagnosis or confirmation of MTHFR, factor V Leiden, and the prothrombin 20210 mutations. Regardless of clinical status, genetic testing can be definitive because the patient's DNA remains constant. Antigen and activity levels must be measured to diagnose the other congenital thrombotic conditions. It is important to understand, however, that the results of activity and antigen level tests can be affected by the clinical state of the patient. In many clinical circumstances, such as those listed below, tests for activity or antigen levels may produce misleading results if the clinical state of the patient is not considered.14,16
Table 2.-Clinical Conditions that Affect Tests for Congenital Thrombotic Risk.
| Clinical Condition |
Effect |
| Heparin therapy or contamination |
Decreases antithrombin |
| Warfarin therapy/vitamin K deficiency |
Decreases protein C and protein S |
| Recent thrombosis or surgery |
Decreases antithrombin, protein C, protein S
Increases homocysteine |
| DIC, liver disease, sepsis, L-asparaginase therapy |
Decreases antithrombin, protein C, protein S |
| Kidney disease/nephrotic syndrome |
Decreases antithrombin and protein S |
Acute phase reaction, inflammation, infection
Increases factor VIII |
Decreases protein S |
| Pregnancy or postpartum period |
Decreases protein S and APCR
Increases homocysteine |
| Oral contraceptives or estrogen replacement |
Decreases antithrombin and protein S |
| Lupus anticoagulants (LA) |
Decreases APCR, protein S, and factor VIII |
Vitamin B12, folate, or B6 deficiency
Treatment with methotrexate, phenytoin, or theophylline
Hypothyroidism, malignancy, menopause
|
Increases homocysteine |
References
|